Raleigh-based Helixomer, a pre-clinical, drug-development company created at North Carolina State University, has won a $2 million federal grant to advance a pair of novel drugs to regulate bleeding and clotting in patients.
Raleigh-based Helixomer, a pre-clinical, drug-development company created at North Carolina State University, has won a $2 million federal grant to advance a pair of novel drugs to regulate bleeding and clotting in patients.
Here's our latest roundup of upcoming events and deadlines across the Triangle through the end of December. This holiday-themed edition features festive parties and other end-of-year events.
Serving readers statewide, here’s our latest preview of upcoming conferences, workshops, deadlines and other events across North Carolina through the end of December. This edition includes several holiday socials.
Serving readers statewide, here’s our latest preview of upcoming conferences, workshops, deadlines and other events across North Carolina through the end of December. This edition includes several holiday socials.